Details for New Drug Application (NDA): 018849
✉ Email this page to a colleague
NDA 018849 describes LIDEX, which is a drug marketed by Alvogen and is included in three NDAs. Additional details are available on the LIDEX profile page.
The generic ingredient in LIDEX is fluocinonide. There are nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.
The generic ingredient in LIDEX is fluocinonide. There are nine drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the fluocinonide profile page.
Summary for 018849
| Tradename: | LIDEX |
| Applicant: | Alvogen |
| Ingredient: | fluocinonide |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018849
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | SOLUTION;TOPICAL | Strength | 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | ||||
| Approval Date: | Apr 6, 1984 | TE: | RLD: | Yes | |||||
Complete Access Available with Subscription
